MOUNT SINAI COMPREHENSIVE CANCER CENTER

What MOUNT SINAI COMPREHENSIVE CANCER CENTER does

Mount Sinai Comprehensive Cancer Center, branded as the Irma and Norman Braman Comprehensive Cancer Center, is the oncology service line of Mount Sinai Medical Center, a private nonprofit hospital system headquartered at 4300 Alton Road in Miami Beach, Florida. The center delivers multidisciplinary cancer care spanning medical oncology, surgical oncology, radiation oncology, and specialized disease-site programs in breast, lung, gastrointestinal, gynecologic, and urologic cancers, supported by medical genetics, psycho-oncology, imaging, and an active clinical trials program. It is led by named chiefs across each subspecialty, including a Director (Dr. Steven N. Hochwald), Chief of Hematologic Malignancies (Dr. Jacqueline Barrientos), Chief of Hematology & Oncology (Dr. Mike Cusnir), and chiefs of Breast Imaging, Radiation Oncology, and Thoracic Surgery, several holding academic appointments at the Zucker School of Medicine at Hofstra/Northwell and the Feinstein Institutes for Medical Research.

The center generates revenue through professional-services billing for clinical encounters, procedures, and treatment programs, paid via commercial insurance, Medicare, Medicaid, and self-pay; pricing is not publicly disclosed. It holds Commission on Cancer (CoC) accreditation from the American College of Surgeons and positions itself as a nationally recognized, award-winning program with more than 70 years of institutional history. Operations are delivered through the main Miami Beach campus plus at least 10 satellite outpatient and emergency locations spanning Miami-Dade and the Florida Keys (Aventura, Coral Gables, Hialeah, Key Biscayne, Key West, Marathon, Miami Shores, Midtown, Skylake, and Sunny Isles), with patient acquisition supported through physician referral, self-referral, and a multi-channel marketing presence including website, blog, YouTube, and earned media.

Name

MOUNT SINAI COMPREHENSIVE CANCER CENTER

Legal name

Mount Sinai Medical Center

Website

https://msccc.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Braman Comprehensive Cancer Center at Mount Sinai Medical Center is a Miami Beach-based nonprofit oncology program delivering multidisciplinary cancer diagnosis, treatment, clinical trials, and supportive care across more than 10 South Florida locations to individual cancer patients.

Ownership category

akta.pro rank

Product category

Cancer Treatment Services

NAICS

General Medical and Surgical Hospitals (622110), Diagnostic Imaging Centers (621512)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Cancer treatment
• Oncology services
• Radiation therapy
• Clinical trials
• Cancer care

Headquarters

HQ city

Miami Beach

HQ country

United States

HQ region

North America

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Services Revenue: Revenue generated from comprehensive cancer care services including medical oncology, surgical oncology, radiation oncology, imaging, and support services. Billed through insurance plans, Medicare, Medicaid, and self-pay patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Mount Sinai Comprehensive Cancer Center is a hospital-based oncology program providing comprehensive cancer diagnosis, treatment, and supportive care for adult cancer patients. It delivers multidisciplinary cancer services spanning medical oncology, surgical oncology, radiation oncology, and dedicated disease-site programs (breast, lung, gastrointestinal, gynecologic, and urologic cancers), complemented by medical genetics, clinical trials, and patient support services.

Product overview

The Braman Comprehensive Cancer Center at Mount Sinai Medical Center is a single, unified cancer treatment program that integrates multiple specialized service centers. The core offering is the nationally recognized Braman Comprehensive Cancer Center, which serves as the central hub organizing specialized treatment areas including Breast Center, Lung Center, Gastrointestinal Cancers, Gynecologic Oncology, Urologic Cancers, along with supporting services (Clinical Trials, Technology & Innovation, Medical Genetics, and Support Services). This hub-and-spoke architecture enables coordinated, multidisciplinary cancer care with specialized expertise in each cancer type while maintaining integrated support services.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology
• Surgical Oncology
• Radiation Oncology
• Breast Center
• Lung Center Dedicated multidisciplinary program for the diagnosis, staging, and treatment of patients with lung cancer and other thoracic malignancies.
• Gastrointestinal (GI) Cancer Program Specialized multidisciplinary program for the diagnosis and treatment of gastrointestinal cancers, including colorectal, pancreatic, gastric, hepatic, and esophageal cancers.
• Gynecologic Oncology Specialized care for cancers of the female reproductive system, including ovarian, uterine, cervical, and vulvar cancers, delivered by gynecologic oncologists.
• Urologic Oncology Specialized multidisciplinary care for cancers of the urinary tract and male reproductive system, including prostate, kidney, and bladder cancers.
• Medical Genetics Genetic counseling and cancer risk assessment services for patients and families with suspected hereditary cancer syndromes, including genetic testing and risk-reduction guidance.
• Clinical Trials Oncology clinical trial enrollment and coordination, providing patients with access to investigational therapies and translational research protocols.
• Cancer Support Services Patient navigation, psychosocial support, survivorship, and related supportive care services for patients and families throughout the cancer care continuum.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• MD Anderson Cancer Center: The leading U.S. NCI-designated Comprehensive Cancer Center; competes indirectly for out-of-region complex oncology cases and provides the gold-standard benchmark for clinical trial portfolio depth and multidisciplinary care that Braman aspires to match at a regional scale.
• City of Hope (formerly Cancer Treatment Centers of America): National NCI-designated system delivering comprehensive cancer care including precision medicine, genomics, and clinical trials; comparable business model for multi-site integrated cancer programs with strong research/clinical-trial positioning.
• Mayo Clinic Comprehensive Cancer Center (Jacksonville): Mayo's Florida campus in Jacksonville operates a Comprehensive Cancer Center with overlapping services including surgical, medical, and radiation oncology; competes for in-state complex-case referrals and draws from the same Florida population base.
• Memorial Sloan Kettering Cancer Center: National NCI-designated cancer center with overlapping sub-specialty services (breast, lung, GI, gyn-onc) and a flagship clinical trials program. Comparable as a benchmark for academic comprehensive cancer program design, though MSK draws cases nationally rather than regionally.

Regional players

• Cleveland Clinic Florida (Maroone Cancer Center): Cleveland Clinic's Florida academic-affiliated site in Weston offers multidisciplinary oncology including breast, GI, and thoracic programs. Competes for South Florida referral cases with a brand anchored to Cleveland Clinic's national reputation.
• NYU Langone Perlmutter Cancer Center: Academic comprehensive cancer center affiliated with the same Hofstra/Northwell ecosystem that Braman's hematologic malignancies chief is academically linked to; comparable structure of multidisciplinary hub-and-satellite oncology operations.
• HCA Florida Healthcare (Oncology Service Line): HCA's Florida network of hospitals operates oncology programs across multiple South Florida communities (Aventura, Kendall, etc.), directly overlapping with several of Braman's satellite catchment areas for community oncology cases.

Direct peers

• Sylvester Comprehensive Cancer Center (University of Miami): NCI-designated academic cancer center in Miami, the most direct head-to-head competitor in South Florida for medical oncology, surgical oncology, and clinical trial enrollment. Overlaps almost entirely on tumor-type service lines and patient catchment.
• Moffitt Cancer Center: Florida-based NCI-designated Comprehensive Cancer Center (Tampa) with a regional referral catchment into South Florida. Direct competitor for complex heme-onc, rare-tumor, and clinical trial cases originating from the Miami metro.
• Baptist Health Miami Cancer Institute: Community-based but research-oriented cancer program located in the same Miami metropolitan area. Competes directly for breast, lung, GI, and radiation oncology patients across South Florida.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCme7J22Fhhv6HnKUzpSamGQ
• LinkedInlinkedin.com/company/mount-sinai-comprehensive-cancer-center

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MOUNT SINAI COMPREHENSIVE CANCER CENTER